Search database
Filter
3640
Text search: vaccine
Featured
Language
Document type
1597
619
515
243
182
181
82
66
57
43
30
13
11
1
Countries
147
144
88
82
82
74
72
70
69
68
60
60
54
50
48
44
43
41
41
40
39
39
38
37
36
36
36
34
31
30
30
29
26
26
25
25
23
22
22
20
19
17
17
16
16
14
14
14
13
12
12
12
12
11
11
11
11
11
9
9
8
8
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
681
175
127
99
98
95
65
52
51
43
42
42
37
37
35
30
24
18
17
17
17
16
16
15
14
14
14
14
13
13
13
13
12
11
10
10
10
10
10
10
10
10
10
10
10
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1430
334
175
146
80
35
33
1
1
Toolboxes
867
224
159
155
154
99
89
87
81
79
69
63
60
58
57
51
50
41
34
20
12
9
1
1
1
 Add to my MEDBOX

Guide to introducing human rabies vaccine into national immunization programmes

World Health Organisation (WHO) (2022) C_WHO
Overview The aim of this guide is to support national immunization programme managers and others responsible for implementing human rabies vaccine programmes to: inform policy discussions and operational planning for introducing or expanding ra ... more
 External Link
 Add to my MEDBOX

Guide to introducing human rabies vaccine into national immunization programmes: Handbook

World Health Organization WHO (2022) C_WHO
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in ch ... more
 Download
  View PDF
 Add to my MEDBOX

Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990–2016)

Ilkelezi et al. Department of Global Health; Institute for Health Metrics and Evaluation (2023) CC
Efforts driving universal coverage have recently been strengthened through implementation of the Global Vaccine Action Plan (GVAP) where cost estimates for immunization support were developed totaling US$40 billion of donor assistance by 2020. In ad ... more
 Add to my MEDBOX

Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy

World Health Organisation (WHO) (2023) C_WHO
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
 Add to my MEDBOX

Enhancing compliance to good manufacturing practices and pharmaceutical quality system requirements in vaccine production: Virtual training marathon kit 2023

World Health Organisation (WHO) (2024) C_WHO
The Virtual cGMP Training Marathon for Vaccine Manufacturing: Principles into Practice took place from 12 Sep to 10 Oct 2023 to continue to provide manufacturers & regulators with a comprehensive array of topics to build understanding of current WHO ... more
 External Link
 Add to my MEDBOX

Traditional and Religious Leaders to Champion New Ebola Vaccine Study in Sierra Leone

Ministry of Health and Sanitation Sierra Leone (2015)
 Download
  View PDF
 Add to my MEDBOX

Integrated Communication Strategy for the Introduction of Oral Cholera Vaccine in Cholera Prevention and Control Programmes

UNICEF (2014)
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DETECTING AND REPORTING ADVERSE DRUG OR VACCINE REACTIONS AND EVENTS IN ZAMBIA

Zambia Medicines Regulatory Authority (ZAMRA) (2006) C2
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
 Download
  View PDF
 Add to my MEDBOX

TB, BCG vaccine and your baby

NHS (2015) C2
Immunisation - the safest way to protect your child
 Download
  View PDF
 Add to my MEDBOX

Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of anEbola outbreak in the Democratic Republic of the Congo

World Health Organization WHO (2019) C_WHO
An example of integration of research into epidemic response.
 External Link
 Add to my MEDBOX

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F.P. et al. (2020) CC
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

World Health Organization WHO (2022) C_WHO
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include ... more
 Add to my MEDBOX

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

World Health Organization WHO (2022) C_WHO
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
recommended

World Health Organization WHO (2022) C_WHO
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s ... more
 Download
  View PDF
 Add to my MEDBOX

Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C1
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
 External Link
 Add to my MEDBOX

UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile

World Health Organization WHO; et al. (2021) C_WHO
12 January 2021
 Add to my MEDBOX

10 steps to community readiness: What countries should do to prepare communities for a COVID-19 vaccine, treatment or new test
recommended

World Health Organization WHO; IFRC; UNICEF and GOARN (2021) C_WHO
8 February 2021 This document highlights 10 well established Risk Communication and Community Engagement (RCCE) principles that have proven their power. Together they put communities at the heart of the roll out of new vaccines, treatments and tests and promote trust, the critical ingredient for al ... more
 Download
  View PDF
 Add to my MEDBOX

Africa Regulatory Taskforce has Endorsed the Emergency Used Listing for Two Versions of the AstraZeneca-Oxford Vaccine

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) C1
AstraZeneca-SKBio in South Korea and Serum Institute of India
 External Link
 Add to my MEDBOX

Possible Side Effects After Getting a COVID-19 Vaccine

Centers for Disease Control and Prevention CDC (2021) C_CDC
COVID-19 vaccination will help protect you from getting COVID-19. You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go away in a few days. Some people have no side effects. ... more
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac

World Health Organization WHO (2022) C_WHO
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been updat ... more
 Add to my MEDBOX

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm (Arabic), updated March 2022

World Health Organization WHO (2022) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Information and Advice for the Home: Understanding the COVID-19 vaccine
recommended

Wesern Cape Government, South Africa; PACK (2021) CC
21 May 2021. he Practical Approach to Care Kit – PACK – is used by nurses, doctors and community health workers in their everyday work to care for patients at the clinic and in the community – PACK Adult, PACK Adolescent, PACK Child and PACK Community. PACK Adult is also known as APC (Adult P ... more
 External Link
 Add to my MEDBOX

The World Bank and the African Union’s COVID-19 Africa Vaccine Acquisition Task Team (AVATT) agree to work together to deploy vaccines for 400million Africans

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
Press Release 14 June 2021
 Add to my MEDBOX

The Critical Role of Community Health Workers in COVID-19 Vaccine Roll Out
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by the Africa CDC was the launch of PACT initiative to accelerate COVID 19 testing. Key to the initiative is the engagement of Community Heal ... more
 Add to my MEDBOX

Factsheet for health workers: Moderna COVID-19 (‎mRNA-1273)‎ vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
July 2021
 External Link
 Add to my MEDBOX

Interim statement on dose-sparing strategies for COVID-19 vaccines (fractionated vaccine doses)

World Health Organization WHO (2021) C_WHO
7 August 2021
 Add to my MEDBOX

Fact sheet for recipients and caregivers - Moderna Covid-19 Vaccine (Kreyol ayisyen)

Food and Drug Administration (2021) CC
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019 (COVID-19) NAN PERSONN 18 ANE AK PI GRAN
 Add to my MEDBOX

DTaP (Diphtheria, Tetanus, Pertussis) Vaccine: What You Need to Know (Kreyol ayisyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC
Vaksen DTaP (Difteri, Tetanòs, Koklich): Sa Ou Bezwen Konnen
 Download
  View PDF
 Add to my MEDBOX

Td (Tetanus, Diphtheria) Vaccine: What You Need to Know (Kreyol ayisyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC
Vaksen Td Sa Ou Bezwen Konnen
 Download
  View PDF
 Add to my MEDBOX

Factsheet for health workers: Sinovac-CoronaVac COVID-19 vaccine, July 2021

World Health Organization WHO (2021) C_WHO
July 2021
 Download
  View PDF
 Add to my MEDBOX

Vaccination against COVID-19 with the Sinovac-CoronaVac COVID-19 vaccine - A quick guide, July 2021

World Health Organization WHO (2021) C_WHO
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to expect following vaccination: ...
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19

World Health Organization WHO (2022) C_WHO
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a ... more
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm (28 October 2021), updated 15 March 2022

World Health Organization WHO (2022) C_WHO
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back ... more
 Add to my MEDBOX

Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons

World Health Organization WHO (2021) C_WHO
Interim guidance, 26 October 2021 This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021. SAGE said moderately and severely immunocompromised persons should be offered an addition ... more
 External Link
 Add to my MEDBOX

Ukraine received more than 700K doses of tetanus-diphtheria vaccine from UNICEF

UN Childrern's Fund Reliefweb OCHA Services (2021) C_UNICEF
To survive and thrive from early childhood through to adolescence and beyond, children need to be healthy. This enables them to access education so that every child in Ukraine, irrespective of background or circumstance, has an equal chance to fulfill their potential. To ensure children thrive and ... more
 Add to my MEDBOX

Liberia Bolsters its Efforts Against Malaria: Launches RTS,S Vaccine in Rivercess County on World Malaria Day

World Health Organisation (WHO) (2024) C_WHO
Rivercess, Liberia, April 25, 2024 - Liberia marks a monumental milestone in its battle against malaria as it launches the highly anticipated RTS,S malaria vaccine today, coinciding with World Malaria Day, commemorated under the theme: Health Equi ... more
 Download
  View PDF
 Add to my MEDBOX

The Short Interval Additional Dose (SIAD) - An intensified campaign approach to deliver monovalent Oral Polio Vaccine (mOPV)

Polio Global Eradication Intiative (2011)
 Add to my MEDBOX

Interim CDC Guidance for Travel to and from Countries Affected by the New Polio Vaccine Requirements

Centers for Disease Control and Prevention CDC (2014)
 External Link
 Add to my MEDBOX

WHO scales up cholera response with 500 000 doses of oral cholera vaccine for vaccination campaign in South Sudan

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Note of the Vatican Covid-19 Commission in collaboration with the Pontifical Academy for Life “Vaccine for all. 20 points for a fairer and healthier world"

Vatican COVID-19 Commission; Pontifical Academy for Life (2021) CC
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
 External Link
 Add to my MEDBOX

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov, D.Y, et al. (2021) C1
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
 Add to my MEDBOX

Statement to African Union Member States on the deployment of the AstraZeneca COVID-19 Vaccine to the continent and concerns about adverse event reports coming from Europe

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) CC
19 March 2021
 External Link
 Add to my MEDBOX

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine

World Health Organization WHO (2021) C_WHO
7 April 2021 Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed. Available in Englisch, French and Russian
 Download
  View PDF
 Add to my MEDBOX

Interim guidance on selecting, commissioning and using freeze-preventative vaccine carriers

World Health Organization WHO (2021) C_WHO
Interim Guidance, published 11 January 2021. The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie ... more
 Download
  View PDF
 Add to my MEDBOX

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended

World Health Organization WHO (2021) C_WHO
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT ... more
 External Link
 Add to my MEDBOX

Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV

European AIDS Clinical Society (EACS) (2021) C2
15 January 2021
 External Link
 Add to my MEDBOX

The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America

Argote P., Barhan E., Zukerman Daly S. et al. NPJ (2021) CC
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vacc ... more
 Add to my MEDBOX

Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a Wo

Driscoll, A.J.; Hasan Arshad, S.; Bont, L. et al. Vaccine (2020) CC
The article reviews the impact of respiratory syncytial virus (RSV) on global health, emphasizing its significant burden on infants, children, and the elderly. It discusses current and emerging prevention strategies, including the development and implementation of vaccines and monoclonal antibodies. ... more
 External Link
 Add to my MEDBOX

How COVID-19 mRNA Vaccines Work
recommended

Vaccine Makers Project (2021) CC
COVID-19 mRNA vaccines deliver directions to make a protein that educates our immune system, so it will neutralize the virus in future encounters. The mRNA-containing lipid particles are taken up by specialized immune system cells
 External Link
 Add to my MEDBOX

Trachoma disease

Trachoma Vaccine TracVac (2021) CC
Trachoma disease Trachoma is a sequela following infection by the bacterium Chlamydia trachomatis (C. trachomatis). The disease is preventable, but still the cause of blindness in 1.9 million people world wide.
 Add to my MEDBOX

Resource Catalogue forService Quality and Experience Literature and Tools

GAVI The Vaccine Alliance (2020) CC
 Add to my MEDBOX

Break COVID Now: The Gavi COVAX AMC Investment Opportunity

Gavi, the Vaccine Alliance (2022) CC
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si ... more
 Download
  View PDF
 Add to my MEDBOX

Accelerator Discussion Paper 1: Sustainable Financing

Global Fund, World Bank Group, Gavi, the Vaccine Alliance et al. World Health Organization (WHO) (2019) CC
The Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) is a set of commitments by 13 multilateral agencies to strengthen their collaboration. For this purpose several accelerators were created and an invitation for public comment was started. This document focuses on Accelerator ... more
 External Link
 Add to my MEDBOX

Meningitis Outbreak Response in Sub-Saharan Africa

Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al World Health Organization WHO (2014) C_WHO
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this ... more
 Download
  View PDF
 Add to my MEDBOX

Surveillance tools for meningitis sentinel hospital surveillance: field guide to rapidly estimate the hospital catchment population (denominator) and the annual rate of hospitalisations

World Health Organization (2015)
The document will provide information for Ministries of Health and hospital sentinel sites on why and how to determine the denominator of at-risk children <5 years of age and rate of meningitis hospitalizations for a sentinel hospital site conducting IB-VPD surveillance. Such a methodology is currently unavailable and this estimation is critical to enable interpretation of surveillance data, particularly pre- and post- ... more
 Add to my MEDBOX

Pengelolaaan Vaksin di Indonesia

Pusat Data dan Informasi Kementerian Kesehatan RI (2016) C1
Vaccine Management in Indonesia
 External Link
 Add to my MEDBOX

Economic burden of cholera in Asia

Vittal Mogasalea, Vijayalaxmi V. Mogasale; Amber Hsiao (2019) CC
https://doi.org/10.1016/j.vaccine.2019.09.099 Our analysis included 14 Asian countries that were estimated to have a total of 850,000 choleracases and 25,500 deaths in 2015 While, the WHO cholera report documented around 60,000 cholera casesand 28 ... more
 External Link
 Add to my MEDBOX

WHO Science in 5 Episode #16 - COVID-19 - How do vaccines work?

World Health Organization WHO (2020) C_WHO
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
 Add to my MEDBOX

WHO Immunological Basis for Immunization Series: Module 14: cholera

World Health Organization WHO (2010) C_WHO
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i ... more
 External Link
 Add to my MEDBOX

How do vaccines work?

World Health Organization WHO (2021) C_WHO
This article is part four in a series of explainers on vaccine development and distribution Available in different languages
 External Link
 Add to my MEDBOX

How are vaccines developed?

World Health Organization WHO (2021) C_WHO
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a ... more
 External Link
 Add to my MEDBOX

Manufacturing, safety and quality control of vaccines

World Health Organization WHO (2020) C_WHO
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a ... more
 External Link
 Add to my MEDBOX

WHO Science in 5 Episode #5 - Vaccines

World Health Organization WHO (2020) C_WHO
When can we expect a vaccine for COVID-19? How will we ensure that it is safe? Who should be vaccinated first and why? Find out the answers to these and other questions.
 External Link
 Add to my MEDBOX

The different types of COVID-19 vaccines

World Health Organization WHO (2020) C_WHO
This article is part four in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a ... more
 External Link
 Add to my MEDBOX

Country readiness for COVID-19 vaccines

World Health Organization WHO (2021) C1
17 February 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explain ... more
 External Link
 Add to my MEDBOX

COVID-19 Vaccination. Recipient Education

Centers for Disease Control and Prevention CDC (2021) CC
Many people have questions about the new coronavirus disease 2019 (COVID-19) vaccines. As vaccine recipients’ most-trusted source of information on vaccines, you play a critical role in helping them understand the importance of COVID-19 vaccinatio ... more
 External Link
 Add to my MEDBOX

WHO in ScienceEpisode #27 - Vaccines, variants & herd immunity

World Health Organization WHO (2021) C_WHO
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in ... more
 External Link
 Add to my MEDBOX

WHO in Science Episode #30 Vaccines-when and why?

World Health Organization WHO (2021) C_WHO
If you have been wondering when you would receive your vaccine? Why you should get vaccinated and are concerned about what your are hearing about side effects, this episode of Science with 5 with WHO’s Chief Scientist Dr Soumya Swaminathan is for ... more
 External Link
 Add to my MEDBOX

How to talk about vaccines

World Health Organization WHO (2021) C_WHO
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. Vacc ... more
 External Link
 Add to my MEDBOX

COVID Behaviors Dashboard
recommended

John Hopkins Center for Communication Programs; World Health Organization WHO, et al. (2021) CC
Global and Regional View of Vaccine Acceptance and Related Behaviors. This new interactive tool captures information on knowledge, attitudes and behaviors around vaccines, masking, testing and more from 12 million people in 115 countries. Insight ... more
 Download
  View PDF
 Add to my MEDBOX

Strategy to Achieve Global Covid-19 Vaccination by mid-2022

World Health Organisation (WHO) (2021) C_WHO
Every country has been affected by COVID-19, with nearly a quarter of a billion cases and almost 5 million deaths reported globally as of end of September 2021. Despite the stunning speed with which highly effective and safe vaccines have been developed, new waves of disease are still pushin ... more
 Add to my MEDBOX

Injection safety in the context of coronavirus disease (COVID-19) vaccination

Infection Prevention and Control UHL, WHO Headquarters (2022) C_WHO
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br ... more
 Download
  View PDF
 Add to my MEDBOX

Treinamento sobre manuseio, armazenamento e transporte da vacina Pfizer BioNTech COVID-19 COMIRNATY® (Tozinameran)

Organización Mundial de la Salud OMS; UNICEF (2020) C_WHO
Vaccine handling, storage and Transportation of Pfizer BioNTech COVID-19 COMIRNATY® (Tozinameran)
 External Link
 Add to my MEDBOX

CDC Global Immunization Strategic Framework 2021–2030

Centers for Disease Control and Prevention CDC (2021) C_CDC
A World of Healthy People Who are Protected from Vaccine-Preventable Disease, Disability, and Death. Progress toward that vision is structured around five capacity building goals, and implemented using four guiding principles, to achieve health impa ... more
 Download
  View PDF
 Add to my MEDBOX

Obtaining proof of vaccination status and assessing vaccination records of refugees from Ukraine

World Health Organization WHO, Regional Office of Europe (2022) C_WHO
Supplement to: Guidance on vaccination and prevention of vaccine-preventable disease outbreaks for countries hosting refugees from Ukraine, April 2022 update This document provides: • information on how to obtain vaccination documentation remotel ... more
 Download
  View PDF
 Add to my MEDBOX

Communicating with caregivers about the Human Papillomavirus vaccination

World Health Organisation (WHO) (2023) C_WHO
This training module is designed to equip health workers (HWs) with knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus (HPV) vaccine.
 Add to my MEDBOX

Development of WHO immunization policy and strategic guidance

World Health Organization WHO (2024) C_WHO
This guidance describes the methods and processes of the Strategic Advisory Group of Experts (SAGE) on Immunization in developing evidence-based recommendations, WHO vaccine position papers, and other immunization policy guidance. Its aim is to faci ... more
 Download
  View PDF
 Add to my MEDBOX

Business case for WHO immunization activities on the African continent 2018-2030

World Health Organization (WHO) (2018) C_WHO
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-p ... more
 Download
  View PDF
 Add to my MEDBOX

WHO AFRO Outbreaks and Other Emergencies, Week 27: 1 - 7 July 2019; Data as reported by 17:00; 7 July 2019

World Health Organization WHO (2019) C_WHO
Circulating vaccine-derived poliovirus type 2 in Angola Ebola virus disease in Democratic Republic of the Congo Dengue fever in Côte d’Ivoire Humanitarian crisis in north-east Nigeria.
 External Link
 Add to my MEDBOX

Vaccines explained
recommended

World Health Organization WHO (2021) C_WHO
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries. ... more
 External Link
 Add to my MEDBOX

WHO Coronavirus (COVID-19) Dashboard Vaccination
recommended

World Health Organization WHO (2021) C_WHO
Find out how many vaccine doses have been given in your country using WHO’s COVID-19 dashboard
 Download
  View PDF
 Add to my MEDBOX

How to manage COVID-19 vaccines without VVM at vaccination service points?

World Health Organization WHO (2021) C_WHO
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered. This document has been updated: 31 August 2021
 External Link
 Add to my MEDBOX

Vaccines explained (Arabic Version)
recommended

World Health Organization WHO (2021) C_WHO
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
 Add to my MEDBOX

Памятка по применению вакцины против COVID-19: вакцина BNT162b2 Comirnaty® компаний Pfizer/BioNTech (‎международное непатентованное наименование: тозинамеран)‎

World Health Organization WHO (2021) C_WHO
Information about vaccine administration
 External Link
 Add to my MEDBOX

Все о вакцинах
recommended

World Health Organization WHO (2021) C_WHO
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries. ... more
 Add to my MEDBOX

Identifying Early Adopters of COVID-19 Vaccines in Latin America

Arrieta, A.; A. García-Prado, J.P. Sarmiento, et al. Florida International University (2021) CC
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is importa ... more
 Add to my MEDBOX

Informe especial de seguridad en vacunas en niños, niñas y adolescentes

la DiCEI del Ministerio de Salud de la Nación en conjunto con la Comisión Nacional de Seguridad en Vacunas (CoNaSeVa) Ministerio de Salud Argentina (2021) CC
Child and adolescent vaccine safety report This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes data from the start of the adolescent campaign in Argentina, includes data reported since the start of t ... more
 Download
  View PDF
 Add to my MEDBOX

Manual del Vacunador Vacuna SINOPHARM - 28 DE FEBRERO DE 2021

Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2021) CC
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
 External Link
 Add to my MEDBOX

Rabies in India

World Health Organization WHO (2022) C_WHO
Rabies is a vaccine-preventable viral disease which occurs in more than 150 countries and territories. Dogs are the source of the vast majority of human rabies deaths, contributing up to 99% of all rabies transmissions to humans.
 External Link
 Add to my MEDBOX

Rabies Key facts

World Health Organization WHO (2023) C_WHO
Rabies is a vaccine-preventable, zoonotic, viral disease affecting the central nervous system. Once clinical symptoms appear, rabies is virtually 100% fatal. In up to 99% of cases, domestic dogs are responsible for rabies virus transmission to human ... more
 Download
  View PDF
 Add to my MEDBOX

Answers to common questions about the Ebola prevention marklate study.

Ministry of Health & Sanitation, Sierra Leone (2015)
Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)
 Add to my MEDBOX

Examining Current Intelligence on COVID-19 and Infection Prevention & Control Strategies in Health Settings - a global analysis

Saiful Islam M. , Mizanur Rahman K., Sun Y., et al. University of Cambridge (2020) CC
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clin ... more
 External Link
 Add to my MEDBOX

Covid-19 vaccines: safety surveillance manual

World Health Organization WHO (2020) C_WHO
22 December 2020 The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vac ... more
 Download
  View PDF
 Add to my MEDBOX

Plano Nacional de Operacionaliza da Vacina contra a COVID-19 : 13 ª edição

Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil Ministerio da Saude Brasilia (2021) C1
National Operationalisation Plan for the COVID-19 Vaccine : 13th edition
 Download
  View PDF
 Add to my MEDBOX

Documento de posición sobre vacunación con la vacuna Sputnik V | Comisión Nacional de Seguridad en Vacunas (CoNaSeVa) | 12 de mayo 2021

Coision Nacional de Seguridad en Vacunas Ministerio de Salud Argentina (2021) CC
Position paper on vaccination with Sputnik V vaccine | National Commission on Vaccine Safety (CoNaSeVa) | 12 May 2021
 Download
  View PDF
 Add to my MEDBOX

OMS lista 9ª vacina contra COVID-19 para uso emergencial para expandir o acesso à vacinação em países de baixa renda, 17 de dezembro de 2021

Organização Mundial da Saúde (OMS) OPAS (2022) C_WHO
WHO lists 9th COVID-19 vaccine for emergency use to expand vaccination access in low-income countries, 17 December 2021
 External Link
 Add to my MEDBOX

Newborn Care Videos: Giving an Intradermal Injection

Global Health Media Project (2014) CC
This film shows how to draw up the BCG vaccine and the correct technique for giving an intradermal injection. http://globalhealthmedia.org/newborn/videos/giving-an-intradermal-injection/
 Add to my MEDBOX

Immunization in the context of COVID-19 pandemic
recommended

World Health Organization & United Nations Children's Fund (‎‎‎‎‎UNICEF)‎‎‎‎‎. (2020) C_WHO
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreas ... more
 Add to my MEDBOX

Immunization in the context of COVID-19 pandemic: frequently asked questions (‎‎‎‎FAQ)‎‎‎‎, 16 April 2020. Arabic Version

World Health Organization WHO; UNICEF (2020) C_WHO
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood ... more
 Download
  View PDF
 Add to my MEDBOX

Frequently Asked Questions (FAQs) about COVID-19 Candidate Vaccines and Access Mechanisms. Version 3, 6 January 2021

Pan American Health Organisation PAHO (2021) C_WHO
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate v ... more